Mark Langhans
Sports Medicine · Rochester, MNNPI 1891236048
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (44.1%), food and beverage and grants — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Arthrex at 38.0% of the total. 2025 is the largest year on record at $2,953, more than ten times the $235 reported in 2022.
Across 75 payments — averaging $99.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Stryker$2K
- Gotham Surgical Solutions & Devices, Inc.$2K
- Zimmer Biomet$242
- Bioventus LLC$77
- Pacira Pharmaceuticals Incorporated$25
- plus $34 from 2 others
What the payments were for
- Grants$1,25917%
- Travel & lodging$3,30344%
- Food & beverage$2,93239%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 28 | $2,846 |
| Stryker | 25 | $2,143 |
| Gotham Surgical Solutions & Devices, Inc. | 13 | $2,125 |
| Zimmer Biomet | 4 | $242 |
| Bioventus LLC | 2 | $77 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Vericel Corporation | 1 | $18 |
| Heron Therapeutics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,494 in reported general payments places this provider in the 80th percentile of 156 sports medicine providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naloxone Hcl | 13 | $737 |
| Ibuprofen | 29 | $179 |
| Meloxicam | 38 | $126 |
| Oxycodone Hcl | 28 | $119 |
| Omeprazole | 18 | $89 |
| Ondansetron Hcl | 18 | $62 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Rochester
- John KellyRochester$11K
- Jacob MikulaRochester$5K
- Fabien MetaRochester$5K
- Erik TherrienRochester$4K
- Brennan BoettcherRochester$4K
- Robert LapradeEdina$1.1M
- Jack SkendzelWoodbury$103K
- Ryan FaderEdina$78K
- Christopher LapradeEagan$64K
- Julie DoddsFairmont$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.